Cited 13 time in
Heparin-regulated prodrug-type macromolecular theranostic systems for cancer therapy
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Wang, H. | - |
| dc.contributor.author | Moon, C. | - |
| dc.contributor.author | Shin, M.C. | - |
| dc.contributor.author | Wang, Y. | - |
| dc.contributor.author | He, H. | - |
| dc.contributor.author | Yang, V.C. | - |
| dc.contributor.author | Huang, Y. | - |
| dc.date.accessioned | 2022-12-26T19:46:37Z | - |
| dc.date.available | 2022-12-26T19:46:37Z | - |
| dc.date.issued | 2017 | - |
| dc.identifier.issn | 2206-7418 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/14908 | - |
| dc.description.abstract | Heparin is a kind of naturally occurring polymer with excellent biocompatibility and solubility. It is characterized by dense of negative charge, higher than any endogenous components. Heparin can bind with various cationic peptides and proteins, thereby providing a useful noncovalent linkage for building a drug delivery system. As a case in point, heparin/cell-penetrating peptides (CPP) interaction is strong, and remains stable in vivo. They can be used to modify different proteins, respectively, and subsequently, by simply mixing the modified proteins, a protein-protein conjugate can be form via the stable heparin/CPP linkage. This linkage could not be broken unless addition of protamine that bears higher cationic charge density than CPP, and CPP thus can be substituted and released. Of note, heparin is a potent antagonist of CPP, and their binding naturally inhibits CPP-mediated drug cell penetration. Based on this method, we developed a heparin-regulated macromolecular prodrug-type system, termed ATTEMPTS, for drug targeting delivery. In this review article, we mainly summary the application of ATTEMPTS in delivery of various macromolecular drugs for cancer therapy, and also introduce the heparin-regulated nanoprobes for tumor imaging. ? Ivyspring International Publisher. | - |
| dc.format.extent | 17 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Ivyspring International Publisher | - |
| dc.title | Heparin-regulated prodrug-type macromolecular theranostic systems for cancer therapy | - |
| dc.type | Article | - |
| dc.publisher.location | 호주 | - |
| dc.identifier.doi | 10.7150/ntno.18292 | - |
| dc.identifier.scopusid | 2-s2.0-85074488329 | - |
| dc.identifier.bibliographicCitation | Nanotheranostics, v.1, no.1, pp 114 - 130 | - |
| dc.citation.title | Nanotheranostics | - |
| dc.citation.volume | 1 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 114 | - |
| dc.citation.endPage | 130 | - |
| dc.type.docType | Review | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.subject.keywordAuthor | Drug targeting delivery | - |
| dc.subject.keywordAuthor | Heparin | - |
| dc.subject.keywordAuthor | Heparin-regulated macromolecular prodrug-type system | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
